Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...
The FARE Innovation Award Diagnostic Challenge is made possible through generous support from the Naddisy Foundation, the ...
Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...
Zacks.com on MSN6h
Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock UpKrystal Biotech KRYS reported fourth-quarter earnings per share of $1.52, which beat the Zacks Consensus Estimate of $1.29 as ...
Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...
Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical ...
Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...
Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback